Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis

Objective: to evaluate the osteoclastogenesis regulatory system – osteoprotegerin/receptor activator of nuclear factor-κβ ligand (OPG/RANKL) system – in men with different clinical types of ankylosing spondylitis (AS).Subjects and methods. The osteoclastogenesis regulatory system was studied in 60 m...

Full description

Saved in:
Bibliographic Details
Main Authors: T. A. Raskina, O. A. Pirogova, O. V. Zobnina, G. A. Pintova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2015-06-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/618
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850040692163739648
author T. A. Raskina
O. A. Pirogova
O. V. Zobnina
G. A. Pintova
author_facet T. A. Raskina
O. A. Pirogova
O. V. Zobnina
G. A. Pintova
author_sort T. A. Raskina
collection DOAJ
description Objective: to evaluate the osteoclastogenesis regulatory system – osteoprotegerin/receptor activator of nuclear factor-κβ ligand (OPG/RANKL) system – in men with different clinical types of ankylosing spondylitis (AS).Subjects and methods. The osteoclastogenesis regulatory system was studied in 60 men, including 40 patients diagnosed with AS complying with the 1984 New York criteria and 20 men without AS. RANKL, a major stimulant of osteoclastogenesis, and OPG, a decoy receptor that binds RANKL and, accordingly, blocks osteoclastogenesis, were investigated.Results. It was shown that in the patients with AS, RANKL concentrations were normal and the content of OPG and OPG/RANKL ratio proved to be significantly higher than those in the men without AS. The highest OPG concentrations were recorded in patients with the axial form of this disease, its moderate activity and early X-ray stage. No relationship was found between the level of RANKL and the clinical characteristics of AS; however, there was a tendency to a slight increase in its concentration in patients with extraskeletal manifestations of AS, its high activity, high functional class, and late X-ray stage.Conclusion. The considerable increase in OPG levels and OPG/RANKL ratio was ascertained to be associated to the fact that 94% of the patients with late-stage AS characterized by the presence of numerous syndesmophytes. These changes must be compensatory in response to modestly increased RANKL level and enhanced bone resorption.
format Article
id doaj-art-d53083dfcbcd429e83ab04d11e78d902
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2015-06-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-d53083dfcbcd429e83ab04d11e78d9022025-08-20T02:56:01ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2015-06-0192232710.14412/1996-7012-2015-2-23-271913Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitisT. A. Raskina0O. A. Pirogova1O. V. Zobnina2G. A. Pintova3Kemerovo State Medical Academy, Ministry of Health of Russia, Kemerovo, Russia 22A, Voroshilov St., Kemerovo 650036Kemerovo State Medical Academy, Ministry of Health of Russia, Kemerovo, Russia 22A, Voroshilov St., Kemerovo 650036Regional Clinical Hospital for War Veterans, Kemerovo, Russia 10, 50 Let Oktyabrya St., Kemerovo 650000Research Institute for Complex Problems of Hygiene and Occupational Diseases, Novokuznetsk, Russia 23, Kutuzov St., Novokuznetsk 654000Objective: to evaluate the osteoclastogenesis regulatory system – osteoprotegerin/receptor activator of nuclear factor-κβ ligand (OPG/RANKL) system – in men with different clinical types of ankylosing spondylitis (AS).Subjects and methods. The osteoclastogenesis regulatory system was studied in 60 men, including 40 patients diagnosed with AS complying with the 1984 New York criteria and 20 men without AS. RANKL, a major stimulant of osteoclastogenesis, and OPG, a decoy receptor that binds RANKL and, accordingly, blocks osteoclastogenesis, were investigated.Results. It was shown that in the patients with AS, RANKL concentrations were normal and the content of OPG and OPG/RANKL ratio proved to be significantly higher than those in the men without AS. The highest OPG concentrations were recorded in patients with the axial form of this disease, its moderate activity and early X-ray stage. No relationship was found between the level of RANKL and the clinical characteristics of AS; however, there was a tendency to a slight increase in its concentration in patients with extraskeletal manifestations of AS, its high activity, high functional class, and late X-ray stage.Conclusion. The considerable increase in OPG levels and OPG/RANKL ratio was ascertained to be associated to the fact that 94% of the patients with late-stage AS characterized by the presence of numerous syndesmophytes. These changes must be compensatory in response to modestly increased RANKL level and enhanced bone resorption.https://mrj.ima-press.net/mrj/article/view/618osteoporosisankylosing spondylitisopgrankl
spellingShingle T. A. Raskina
O. A. Pirogova
O. V. Zobnina
G. A. Pintova
Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
Современная ревматология
osteoporosis
ankylosing spondylitis
opg
rankl
title Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
title_full Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
title_fullStr Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
title_full_unstemmed Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
title_short Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
title_sort indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
topic osteoporosis
ankylosing spondylitis
opg
rankl
url https://mrj.ima-press.net/mrj/article/view/618
work_keys_str_mv AT taraskina indicatorsoftheosteoclastogenesissysteminmenwithdifferentclinicaltypesofankylosingspondylitis
AT oapirogova indicatorsoftheosteoclastogenesissysteminmenwithdifferentclinicaltypesofankylosingspondylitis
AT ovzobnina indicatorsoftheosteoclastogenesissysteminmenwithdifferentclinicaltypesofankylosingspondylitis
AT gapintova indicatorsoftheosteoclastogenesissysteminmenwithdifferentclinicaltypesofankylosingspondylitis